1. Encephalitis related to immunotherapy for lung cancer: Analysis of a multicenter cohort. (May 2020) Authors: Sanchis-Borja, Mateo; Ricordel, Charles; Chiappa, Anne Marie; Hureaux, José; Odier, Luc; Jeannin, Gaelle; Descourt, Renaud; Gervais, Radj; Monnet, Isabelle; Auliac, Jean-Bernard; Chouaïd, Christos Journal: Lung cancer Issue: Volume 143(2020) Page Start: 36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PD-L1-expression patterns in large-cell neuroendocrine carcinoma of the lung: potential implications for use of immunotherapy in these patients: the GFPC 03-2017 "EPNEC" study. (July 2020) Authors: Arpin, Dominique; Charpentier, Marie-Christine; Bernardi, Marie; Monnet, Isabelle; Boni, Aurelie; Watkin, Emmanuel; Goubin-Versini, Isabelle; Lamy, Régine; Gérinière, Laurence; Geier, Margaux; Forest, Fabien; Gervais, Radj; Madrosyk, Anne; Guisier, Florian; Serrand, Cécile; Locher, Chrystèle; Dec... Journal: Therapeutic advances in medical oncology Issue: Volume 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Immunotherapy rechallenge after nivolumab treatment in advanced non-small cell lung cancer in the real-world setting: A national data base analysis. (February 2020) Authors: Giaj Levra, Matteo; Cotté, François-Emery; Corre, Romain; Calvet, Christophe; Gaudin, Anne-Françoise; Penrod, John R.; Grumberg, Valentine; Jouaneton, Baptiste; Jolivel, Ronan; Assié, Jean-Baptiste; Chouaïd, Christos Journal: Lung cancer Issue: Volume 140(2020) Page Start: 99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Factors associated with early lung cancer mortality: a systematic review. Issue 10 (3rd October 2021) Authors: Goussault, Helene; Gendarme, Sebastien; Assié, Jean Baptiste; Bylicki, Olivier; Chouaïd, Christos Journal: Expert review of anticancer therapy Issue: Volume 21:Issue 10(2021) Page Start: 1125 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Phase III randomized study of carboplatin pemetrexed with or without bevacizumab with initial versus "at progression" cerebral radiotherapy in advanced non squamous non-small cell lung cancer with asymptomatic brain metastasis. (April 2021) Authors: Monnet, Isabelle; Vergnenègre, Alain; Robinet, Gilles; Berard, Henri; Lamy, Regine; Falchero, Lionel; Vieillot, Sabine; Schott, Roland; Ricordel, Charles; Chouabe, Stephane; Thomas, Pascal; Gervais, Radj; Madroszyk, Anne; Abdiche, Samir; Chiappa, Anne Marie; Greillier, Laurent; Decroisette, Chant... Journal: Therapeutic advances in medical oncology Issue: Volume 13(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Real-world effectiveness of immunotherapies in pre-treated, advanced non-small cell lung cancer Patients: A systematic literature review. (April 2022) Authors: Juarez-Garcia, Ariadna; Sharma, Ruchika; Hunger, Matthias; Kayaniyil, Sheena; Penrod, John R.; Chouaïd, Christos Journal: Lung cancer Issue: Volume 166(2022) Page Start: 205 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. LUCSO-1—French pilot study of LUng Cancer Screening with low-dose computed tomography in a smokers population exposed to Occupational lung carcinogens: study protocol. Issue 3 (23rd March 2019) Authors: Delva, Fleur; Laurent, François; Paris, Christophe; Belacel, Milia; Brochard, Patrick; Bylicki, Olivier; Chouaïd, Christos; Clin, Benedicte; Dewitte, Jean-Dominique; Le Denmat, Véronique; Gehanno, Jean-François; Lacourt, Aude; Margery, Jacques; Verdun-Esquer, Catherine; Mathoulin-Pélissier, Simon... Journal: BMJ open Issue: Volume 9:Issue 3(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Long-term hospital resource utilization and associated costs of care for patients initiating nivolumab in advanced non-small cell lung cancer in France. (31st December 2022) Authors: Grumberg, Valentine; Chouaïd, Christos; Cotté, François-Emery; Jouaneton, Baptiste; Jolivel, Ronan; Gaudin, Anne-Françoise; Reynaud, Dorothée; Assié, Jean-Baptiste; Borget, Isabelle Journal: Journal of medical economics Issue: Volume 25:Number 1(2022) Page Start: 691 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Risk factors for early mortality of lung cancer patients in France: A nationwide analysis. (14th May 2022) Authors: Goussault, Hélène; Gendarme, Sébastien; Assié, Jean‐Baptiste; Jung, Camille; Epaud, Salomé; Algans, Christelle; Salaun‐Penquer, Noémie; Rousseau, Mathilde; Lazatti, Andrea; Chouaïd, Christos Journal: Cancer medicine Issue: Volume 11:Number 24(2022) Page Start: 5025 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Nivolumab treatment in advanced non-small cell lung cancer: real-world long-term outcomes within overall and special populations (the UNIVOC study). (October 2020) Authors: Assié, Jean-Baptiste; Corre, Romain; Levra, Matteo Giaj; Calvet, Christophe Yannick; Gaudin, Anne-Françoise; Grumberg, Valentine; Jouaneton, Baptiste; Cotté, François-Emery; Chouaïd, Christos Journal: Therapeutic advances in medical oncology Issue: Volume 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗